INSIGHTS ON DRUG DEVELOPMENT

• Advancing Multiomics Through Intelligent Automation

  Modern automation tackles hidden pipetting errors and boosts reproducibility. Discover how your lab can scale confidently, reduce rework, and accelerate multiomic workflows with built-in traceability.

• Direct Amplification Of Samples Associated With Strawberry Leaf Punches

  Skip extraction and still achieve reliable qPCR results. See how direct amplification of plant samples enables faster workflows, lower costs, and clear detection of resistance markers.

• Immuno-Oncology Biomarker Measurement With High Sensitivity And Speed

  Explore results demonstrating the successful use of innovative ELISA assays to detect three key biomarkers: Programmed Death Ligand 1 (PD-L1), Interleukin-8 (IL-8), and Interferon Gamma (IFN-γ).

• Highly Sensitive ELISAs In 90 Minutes

  Traditional ELISA methods are often limited by their relatively low throughput and need for multiple wash steps. Learn about a solution that overcomes these challenges and provides rapid results.

• Combining Patient Centricity And Commercial Viability In Pediatric Product Development

  8/15/2024

  Medication acceptance and adherence are critical concerns in pediatric populations due to these patients’ rapid anatomical and physiological development.

• Predicting Performance Of Lotions Through Rheological Characterization

  5/6/2026

  Rheological testing shows how small formulation differences influence spreading, flow, and feel during use. With minimal sample volumes, these methods connect lab measurements to real‑world performance.

• Automating High-Throughput Screens Using Patient-Derived Organoids

  3/17/2025

  Many oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.

• Studying The Spatial Architecture Of Glioblastoma

  3/24/2025

  Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).

• A Simple And Powerful Solution For Accelerating Dissolution

  5/5/2026

  Many poorly soluble drugs fail not because of low solubility, but because they dissolve too slowly. Learn how focusing on dissolution rate can unlock absorption gains using simple strategies.